Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Walters

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
International Journal of Medical Microbiology : IJMM|February 21, 2006
Quorum sensing in Escherichia coli and SalmonellaMatthew Walters, Vanessa Sperandio
British Medical Bulletin|November 9, 2006
New and emerging treatments for strokeJesse Dawson, Matthew Walters
The Lancet. Neurology|October 22, 2005
Development and validation of a stroke recognition toolJesse Dawson, Matthew Walters
The American Journal of Medicine|August 31, 2010
A distracting stroke and the erythematous flagChristos Tziotzios, Matthew Walters
Infection and Immunity|September 22, 2006
Autoinducer 3 and epinephrine signaling in the kinetics of locus of enterocyte effacement gene expression in enterohemorrhagic Escherichia coliMatthew Walters, Vanessa Sperandio
British Journal of Clinical Pharmacology|September 8, 2011
Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease?Jesse Dawson, Matthew Walters
Veterinary Parasitology|April 13, 2012
Evaluation of dicyclanil (CLiKZiN®) treatment for the early-season protection of ewes against blowfly strikeMatthew Walters, Richard Wall
Current Medicinal Chemistry|July 14, 2007
Uric acid reduction: a new paradigm in the management of cardiovascular risk?Jesse Dawson, Terry Quinn, Matthew Walters
Nature Nanotechnology|February 1, 2011
Nanomedicine: Nanotubes reduce stroke damagePeter Higgins, Jesse Dawson, Matthew Walters
Heart (British Cardiac Society)|March 8, 2011
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (NICE technology appraisal guidance 90)Kirsty Stewart, Matthew Walters, Jesse Dawson
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
International Journal of Medical Microbiology : IJMM|February 21, 2006
Quorum sensing in Escherichia coli and SalmonellaMatthew Walters, Vanessa Sperandio
British Medical Bulletin|November 9, 2006
New and emerging treatments for strokeJesse Dawson, Matthew Walters
The Lancet. Neurology|October 22, 2005
Development and validation of a stroke recognition toolJesse Dawson, Matthew Walters
The American Journal of Medicine|August 31, 2010
A distracting stroke and the erythematous flagChristos Tziotzios, Matthew Walters
Infection and Immunity|September 22, 2006
Autoinducer 3 and epinephrine signaling in the kinetics of locus of enterocyte effacement gene expression in enterohemorrhagic Escherichia coliMatthew Walters, Vanessa Sperandio
British Journal of Clinical Pharmacology|September 8, 2011
Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease?Jesse Dawson, Matthew Walters
Veterinary Parasitology|April 13, 2012
Evaluation of dicyclanil (CLiKZiN®) treatment for the early-season protection of ewes against blowfly strikeMatthew Walters, Richard Wall
Current Medicinal Chemistry|July 14, 2007
Uric acid reduction: a new paradigm in the management of cardiovascular risk?Jesse Dawson, Terry Quinn, Matthew Walters
Nature Nanotechnology|February 1, 2011
Nanomedicine: Nanotubes reduce stroke damagePeter Higgins, Jesse Dawson, Matthew Walters
Heart (British Cardiac Society)|March 8, 2011
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (NICE technology appraisal guidance 90)Kirsty Stewart, Matthew Walters, Jesse Dawson
Pageof 11